Aeterna Zentaris Inc. (AEZS) Financials
AEZS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 31.8 million | 18.8 million |
| 2023-12-31 | 36.8 million | 18.7 million |
| 2023-09-30 | 42.5 million | 16.2 million |
| 2023-06-30 | 46.5 million | 17.4 million |
AEZS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | -4.3 million | 8000 |
| 2023-12-31 | -5.5 million | 28000 |
| 2023-09-30 | -3.4 million | 27000 |
| 2023-06-30 | -4.3 million | 306000 |
AEZS Net Income
No data available :(
AEZS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | - | - | 234000 |
| 2023-12-31 | 33.8 million | - | 279000 |
| 2023-09-30 | 38.8 million | - | 217000 |
| 2023-06-30 | 42.2 million | - | 230000 |
AEZS Shares Outstanding
AEZS Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 5000 | 2.6 million | 3.5 million | - |
| 2023-12-31 | 5121 | 4.0 million | 2.6 million | 27505 |
| 2023-09-30 | 9000 | 2.8 million | 1.8 million | - |
| 2023-06-30 | 3000 | 2.9 million | 2.0 million | - |
AEZS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 4000 | 16000 |
| 2023-12-31 | 124344 | 100708 |
| 2023-09-30 | 3000 | 11000 |
| 2023-06-30 | 2.2 million | 139000 |
AEZS
Price: $9.93
52 week price:
Earnings Per Share: -13.64 USD
P/E Ratio: -0.37
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 19700
Ebitda: -7.2 millionMarket Capitalization: 10.4 million